» Articles » PMID: 7768248

Sensitivity of Residual Nephrons to High Dose Furosemide Described by Diuretic Efficiency

Overview
Specialty Pharmacology
Date 1995 Jan 1
PMID 7768248
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Ten haemodialysis (HD) patients with a median residual creatinine clearance (CLCR) of 1.9 ml.min-1 x 1.73 m-2 (range 0.6-5.3) were treated with oral furosemide (F) 2.0 g. Overall-efficiency (O-E, daily sodium excretion/total urinary F) and total-efficiency (delta-E, increase in daily sodium excretion/total urinary F) were measured on the last 24 hours of each interdialysis interval. In addition, O-E was measured during the complete interdialysis interval in 10 HD patients with a median CLCR of 5.6 ml.min-1 x 1.73 m-2 (range 0.7-6.8) treated for 1 year with a fixed oral dose of F between 250-1000 mg (median 625 mg). In the short study the median O-E was 10.6 mmol.mg-1 (range 1.9-22.0) and delta-E 6.2 mmol.mg-1 (range 1.3-11.2). The fractional excretion of sodium FENa was significantly increased from 9.6% (range 4.1-22.9) to 27% (range 14.6-56.2) during F treatment. A positive correlation was found between the basal FENa and delta-E. In the long-term study median O-E was 6.4 mmol.mg-1. O-E and FENa showed no change over time although median RCC decreased from 5.6 to 1.9 ml.min-1 x 1.73 m-2 and median F excretion from 11.8 to 7.5 mg per day. It can be concluded that diuretic efficiency in haemodialysis patients is dependent on FENa and the state of hydration during the interdialysis interval.

Citing Articles

Diuretic use in renal disease.

Sica D Nat Rev Nephrol. 2011; 8(2):100-9.

PMID: 22183505 DOI: 10.1038/nrneph.2011.175.


Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis.

Lemes H, Araujo S, Nascimento D, Cunha D, Garcia C, Queiroz V Clin Exp Nephrol. 2011; 15(4):554-9.

PMID: 21416248 DOI: 10.1007/s10157-011-0427-z.


The importance of residual renal function in chronic dialysed patients.

Radulescu D, Ferechide D J Med Life. 2010; 2(2):199-206.

PMID: 20108541 PMC: 3018976.


Diuretics in pediatrics : current knowledge and future prospects.

van der Vorst M, Kist J, van der Heijden A, Burggraaf J Paediatr Drugs. 2006; 8(4):245-64.

PMID: 16898855 DOI: 10.2165/00148581-200608040-00004.

References
1.
Loon N, Wilcox C, Unwin R . Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int. 1989; 36(4):682-9. DOI: 10.1038/ki.1989.246. View

2.
Kerremans A, Tan Y, van Ginneken C, Gribnau F . Specimen handling and high-performance liquid chromatographic determination of furosemide. J Chromatogr. 1982; 229(1):129-39. DOI: 10.1016/s0378-4347(00)86044-2. View

3.
Voelker J, Anderson S, Leinfelder J, Sica D, Kokko J, Brater D . Comparison of loop diuretics in patients with chronic renal insufficiency. Kidney Int. 1987; 32(4):572-8. DOI: 10.1038/ki.1987.246. View

4.
Holford N, Sheiner L . Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet. 1981; 6(6):429-53. DOI: 10.2165/00003088-198106060-00002. View

5.
Brater D . Clinical pharmacology of loop diuretics. Drugs. 1991; 41 Suppl 3:14-22. DOI: 10.2165/00003495-199100413-00004. View